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ABSTRACT
MicroRNAs (miRNAs) are an important class of
small noncoding RNAs capable of regulating other
genes’ expression. Much progress has been made
in computational target prediction of miRNAs in
recent years. More than 10 miRNA target prediction
programs have been established, yet, the predic-
tion of animal miRNA targets remains a challenging
task. We have developed miRecords, an integrated
resource for animal miRNA–target interactions. The
Validated Targets component of this resource hosts
a large, high-quality manually curated database of
experimentally validated miRNA–target interactions
with systematic documentation of experimental
support for each interaction. The current release of
this database includes 1135 records of validated
miRNA–target interactions between 301 miRNAs
and 902 target genes in seven animal species.
The Predicted Targets component of miRecords
stores predicted miRNA targets produced by 11
established miRNA target prediction programs.
miRecords is expected to serve as a useful
resource not only for experimental miRNA research-
ers, but also for informatics scientists develop-
ing the next-generation miRNA target prediction
programs. The miRecords is available at http://
miRecords.umn.edu/miRecords.
INTRODUCTION
MicroRNAs (miRNAs) are a class of small (19–27nt)
noncoding RNAs capable of base-paring to the transcripts
of protein-coding genes (which are termed the targets of
the miRNAs), leading to downregulation or repression of
the targeted genes(1–3). The miRNA gene family is one of
the largest in higher eukaryotes: more than 700 mature
miRNAs have been identiﬁed in the human genome,
according to the current release of miRBase (4), and
these miRNAs account for >2.5% of all human genes.
The exact mechanisms by which miRNAs regulate their
target genes’ expression remain obscure, although several
models have been proposed [see recent reviews, e.g. (5,6)],
suggesting that miRNAs could induce translation repres-
sion at both the initiation phase and the elongation
phase of translation. Alternatively, the translation may
not be directly aﬀected, but miRNAs could lead to rapid
proteolysis of nascent polypeptides; or they may lead to
accumulation of target mRNAs in the P-bodies, isolating
them from the translation machinery (5,6). The miRNAs
could also lead to degradation of the target transcripts.
Recent evidence suggests that miRNA-induced target
transcript degradation through a complex process that
includes the deadenylation and decapping of mRNAs,
distinct from the siRNA-induced RNA silencing mech-
anism (6,7).
Computational prediction of miRNA targets is much
more challenging in animals than in plants, because
animal miRNAs often form imperfect base-pairing with
their target sites (3,8–11), unlike plant miRNAs which
almost always bind their targets with near perfect comple-
mentarity (12). In the past several years, a large number
of target prediction programs have been developed for
animal miRNAs [see recent reviews, e.g. (8,10,11,13)].
Several of the earliest target prediction programs [includ-
ing TargetScan (14)/TargetScanS (15), PicTar (16),
miRanda (17,18), DIANA-microT (19) and MicroInspec-
tor (20)] adopted hand-derived rules based on a number
of principles summarized from known miRNA–target
interactions. These principles emphasize: (i) near-perfect
complementarity in the 6–8nt region close to the 50 end
of the miRNA (the so-called ‘seed’ region) with the
30UTR region of the target sequence; (ii) evolutionary
conservation of the target sequences between species;
(iii) strong thermodynamic stability of miRNA–mRNA
duplex; (iv) cooperativity between multiple sites in close
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region (forming a loop or bulge). RNAhybrid (21), one
of the earliest developed miRNA target prediction pro-
gram, implemented an eﬃcient algorithm that ﬁnds
energetically most favorable hybridizations between the
miRNA and mRNA molecules, avoiding intramolecular
hybridizations. A newer miRNA target prediction pro-
gram, Rna22 (22), applied a procedure that ﬁrst ﬁnds
signiﬁcant sequence motifs (or ‘patterns’) among all
known miRNA sequences, then deﬁnes ‘target islands’,
or regions in mRNAs where reverse complements of the
miRNA patterns aggregate and focuses on these target
islands when searching for miRNA target sites. Most
recently developed miRNA target prediction programs
[miTarget (23), MirTarget2 (24) and NBmiRTar (25)]
employed machine learning techniques to construct pre-
dictors directly from validated miRNA target datasets.
Furthermore, several recent studies suggested that target
site accessibility is an important factor for eﬀective target-
ing of miRNAs (26–28). One program, PITA, was devel-
oped to make predictions based on target site accessibility
features.
Comparative studies conducted with the earlier miRNA
target prediction programs (including TargetScanS,
PicTar, miRanda, DIANA-microT, RNAhybrid, Micro-
Inspector and Rna22) suggested that no one program was
consistently superior to all others (13,29). Indeed, it has
become a common practice for experimental research-
ers to look at predictions made by several target predic-
tion programs and focus on their intersections (30,31).
Machine learning methods have good potential to produce
more accurate target predictors. Yet, recently developed
machine-learning-based target prediction tools (miTarget,
MirTarget2 and NBmiRTar) have not been through rig-
orous independent assessments. The performance of
machine learning-based methods is known to be heavily
dependent on the quantity and quality of the dataset used
in the training. The lack of large, high-quality datasets
of experimentally validated miRNA targets will likely be
the bottleneck for developing more accurate miRNA
target prediction programs.
Here, we present miRecords, a new resource for animal
miRNA–target interactions. miRecords consists of two
components. The Validated Targets component is a
large, high-quality database of experimentally validated
miRNA targets resulting from meticulous manual litera-
ture curation. As the largest known collection of experi-
mental validated miRNA targets, it emphasizes systematic
and structured documentation of experimental support of
miRNA–target interactions. This database not only serves
the experimental researchers by providing the lists of con-
ﬁrmed targets of the miRNAs of their interest, but also
provides a large and high-quality dataset that will facil-
itate the development of the next-generation miRNA
target prediction programs. The Predicted Targets com-
ponent of miRecords is an integration of predicted
miRNA targets produced by 11 established miRNA
target prediction programs. As the most complete inte-
gration of predicted miRNA targets, it is expected to
provide considerable help to researchers investigating
new miRNA targets.
DATABASE CONTENT
Key issues in documentingvalidated targets
The Validated Targets component of miRecords is
designed to serve as a centralized archive of conﬁrmed
miRNA–target interactions with systematic documenta-
tion of experimental support. To ensure the usefulness
of this database to the miRNA research community at
large, it is critical to identify key issues involving experi-
mental validations of miRNA–target interactions, and
carefully incorporate them into the documenting system.
Endogenous miRNAs versus exogenous miRNAs. A
majority of studies of miRNA–target interactions were
performed by experimental manipulations of the level
of a miRNA (either by overexpression/misexpression or
by underexpression) in a cell line or a tissue, followed by
examination of changes in expression of the putative tar-
gets. These experiments could be generally classiﬁed as
‘exogenous miRNA experiments’.
Concerns have been raised, however, over how many of
these miRNA–target interactions actually take place in
endogenous, physiological conditions (32,33). Similarly
to the gene regulation by transcription factors, endogen-
ous miRNA may require favorable cellular context to bind
and regulate their targets, which cannot be replicated in
exogenous miRNA experiments.
An increasing number of studies have provided evidence
about endogenous miRNA–target interactions. For exam-
ple, in Ref. (34), when investigating whether let-60 was a
target of the miRNA let-7 in the hypodermal seam cells in
Caenorhaditis elegans, the authors fused let-60 30UTR
behind the Escherichia coli lacZ gene. They discovered
that the reporter activity was downregulated at the L4
stage of the development, when let-7 was known to be
expressed in the seam cells. In contrast, the same reporter
gene fused to an irrelevant control 30UTR was expressed
at all stages. As another example, in Ref. (33), the target-
ing of cog-1 by the miRNA lsy-6 was studied in the ASEL
and ASER, two closely related bilaterally symmetric neu-
rons in C. elegans. The ASEL, but not the ASER, neuron
expresses endogenous lsy-6. The authors fused the cog-1
30UTR to a green ﬂuorescent protein (GFP) sensor con-
struct, and found that this fusion was eﬀectively down-
regulated in ASEL but not in ASER. In several other
studies, the endogenous levels of miRNAs and the protein
expression levels of their potential targets were measured
simultaneously across several cell lines or specimens, and
inverse correlations were observed between them (35–37).
In miRecords, we make a clear distinction between
endogenous miRNA experiments and exogenous
miRNA experiments. For each study involving endogen-
ous miRNA experiments, we provide a brief summary
about the rationale of the experiments as well as an expla-
nation of the results.
Target genes, target regions and target sites. We classify
any experimental evidence about miRNA–target interac-
tion as belonging to one of the three levels: the target gene
level, the target region level and the target site level. When
the evidence indicates that the level of the full-length gene
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reduced following over- or misexpression of a miRNA,
or that the full-length gene product has accumulated
following underexpression of the miRNA, it is considered
as target gene level evidence. The target gene level evi-
dence also includes endogenous miRNA experiments lead-
ing to the ﬁnding of inverse correlations between the
endogenous miRNA levels and the full-length protein
products of the putative target genes. The target gene
level experiments are often regarded as indirect support
of the miRNA–target interactions, because the level of
the gene product may change due to other reasons, e.g.
a change in expression of another protein (which is a true
target of the miRNA) that it interacts with.
When the experimental evidence indicates that a region
of the mRNA of the putative target (shorter than the full-
length transcript) is responsible for the miRNA–target
interaction, it is documented as target region level evi-
dence. Most target region level experiments were con-
ducted with fusion of the 30UTR of the putative target
gene (or a section of the 30UTR) to a reporter construct
(e.g. luciferase or GFP), followed by observations that the
reporter expression is downregulated (or upregulated) in
response to overexpression/misexpression (or underex-
pression) of the miRNA.
When an experiment points to a very short section of
the mRNA (whose length is comparable with that of the
miRNA) as being responsible for the miRNA–target inter-
action, it is classiﬁed as target site level evidence. The
target site level experiments include reporter assays with
fusion constructs made with short target sites, and target
site mutation experiments (discussed below).
Over- or misexpression and underexpression of
miRNAs. The exogenous miRNA experiments can be
broadly classiﬁed into two categories based on the
methods by which the miRNA levels are manipulated:
miRNA overexpression or misexpression experiments,
and miRNA underexpression experiments. The methods
commonly applied to over- or misexpress miRNAs include
mature miRNA transfection (38), miRNA precursor
transfection (39) and indirectly induced miRNA over-
expression [using the DNA demethylatingn agent 5-Aza-
Deoxycytidine (40), or the histone deacetylase inhibitor
phenylbutyrate (PBA) (41)]. The techniques applied to
underexpress miRNAs include miRNA knockdown by
siRNAs (42), miRNA knockdown by antisense modiﬁed
oligonucleotides, e.g. morpholinos (43), locked nucleic
acids (44), or 20-O-Me oligonucleotides (45) and knockout
of the miRNA gene (46).
Reporter assays, mRNA- and protein-level
measurements. The means by which putative target
expression levels are examined can be classiﬁed into four
categories: reporter assays, mRNA-level measurements,
protein-level measurements and ‘others’. In a reporter
assay, the putative target region or target site is fused
with a reporter vector, and the expression level of the
putative target region or target site is quantiﬁed by
measuring the reporter’s activity. Commonly used repor-
ters include luciferase (16), GFP (47), YFP (43) and the
lacZ/b-galactosidase reporter (48). Several methods of
measuring mRNA levels of putative targets can be
applied. They include RT–PCR (28), northern blot (49),
50RACE (50), DNA microarrays (51), ribonuclease pro-
tection assay (52) and branched DNA probe assay (53).
Commonly applied protein-level measuring methods
include western blot (54), ELISA (55) and immunocyto-
chemistry (56). The ‘others’ category includes rare target
expression analyses that do not belong to other categories,
e.g. phenotype analysis (43).
Target site mutations. In a target site mutation experi-
ment, point mutations are introduced to the putative
target site. If the introduced point mutations lead to abol-
ishment of the miRNA-mediated downregulation, the site
is convincingly veriﬁed as a true target site. Besides vali-
dating miRNA target sites, target site mutation experi-
ments are frequently conducted in studies investigating
general features that inﬂuence the miRNA targeting, e.g.
it was applied to study the importance of the 50 seed region
for miRNA–target interactions (9), and of target accessi-
bility features in assisting miRNA target discovery (26).
Webinterface
The miRecords resource can be accessed through the URL
http://miRecords.umn.edu/miRecords. In the Validated
Targets section, the user can ﬁrst select a species, then
choose from a list of miRNAs for which experimentally
validated targets have been documented. Optionally, the
user can provide the RefSeq accession, the Entrez Gene
ID or the gene name of the target gene and initiate a
search. The result of the search is presented as a list
of miRNA–target interactions. For each miRNA–target
interaction, the information about the miRNA and
about the target gene is displayed together with the pre-
diction results of 11 established miRNA target prediction
programs. Positive predictions are indicated by lit up sym-
bols. The user can click a lit up symbol to obtain more
information about the prediction.
When the user clicks the ‘Click for detail’ link displayed
in the ‘Target Interaction’ column, detailed information
about a validated miRNA–target interaction is presented.
The detailed information about the miRNA includes the
Stemloop ID and accession number, mature miRNA ID
and accession number and the sequence of the miRNA.
The detailed information about the target gene includes
the RefSeq accession number, name, synonyms and the
description of the gene.
Underneath the general information about the miRNA
and the target gene, all records, or literature accounts of
the miRNA–target interaction are presented. On the top
of each record is the citation information, underneath
which is the experimental support of the miRNA–target
interaction, listed in the order of the target gene level
evidence, followed by the target region level evidence,
then by the target site level evidence. In each of the
three levels of evidence, endogenous miRNA experiments
(when available) are described ﬁrst, followed by summa-
ries of exogenous miRNA experiments. The summary of a
target gene level, exogenous miRNA experiment includes
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expression by mature miRNA transfection’, or ‘under-
expression by siRNA knock-down’), reporter assay
performed (e.g. luciferase assay), mRNA-level measure-
ment performed (e.g. RT–PCR or 50RACE), mRNA-
level measurement result (e.g. ‘down-regulated’), protein-
level measurement performed (e.g. western blot) and
protein-level measurement result. The user can click
the ‘Detail’ button for each individual experiment, and
the description of the experiment from the original pub-
lication is displayed.
The summary of target gene level or target site level
evidence also includes the section of the mRNA that
was used in the fusion reporter assay, and about whether
point mutation experiments were performed. When avail-
able, a drawing of the alignment between the miRNA and
the putative target site is also presented.
The user can download the complete dataset of vali-
dated targets at the Download Validated Targets section
accessible from the top of the web site.
The Predicted Targets section is organized similarly to
the Validated Targets section. When the user submits a
query, all putative targets (including unvalidated ones)
predicted by one or more of the established miRNA
target prediction programs are presented. The user can
choose to display the result according to the predictions
made by a particular target prediction program, and/or
apply a ﬁlter to display putative targets predicted by at
least a user-speciﬁed number of prediction programs.
Moreover, an option is provided for the user to download
the predicted targets of interest to his or her local compu-
ter for further examination.
Data access
The miRecords web site is publically accessible through
the URL http://miRecords.umn.edu/miRecords. Addi-
tional requests can be made by emailing to miRecords@
biocompute.umn.edu.
Implementation
The miRecords resource is constructed as a relational
database implemented with MySQL on a Fedora Core 6
Linux system. The front-end web interface is implemented
as a PHP project running under Apache 2.0.
COMPARISON WITH OTHER miRNA TARGET
RESOURCES
TarBase is a well-known database of experimentally vali-
dated miRNA targets (57). Comparison between TarBase
and miRecords (the Validated Targets component) sug-
gests that miRecords hosts a much more complete collec-
tion of miRNA–target interactions than TarBase
(Table 1). Moreover, miRecords adopts a consistent and
organized scheme of documenting the experimental
support for miRNA–target interactions, in which endo-
genous miRNA experiments are distinguished from
exogenous miRNA experiments, three levels of experi-
mental evidence—the target gene level, the target region
level and the target site level are clearly diﬀerentiated,
and details of reporter assays, mRNA-level and protein-
level measurements and target-site-mutation studies
are systematically documented. This is in contrast to the
documenting scheme adopted by TarBase, which only
broadly classiﬁes all targets as either ‘translationally
repressed targets’ or ‘downregulated/cleaved targets’,
and provides only limited information about ‘single site
suﬃciency’, ‘direct support’ and ‘indirect support’ for the
miRNA–target interactions.
The Predicted Targets component of miRecords
integrates the miRNA targets predicted by 11 existing
miRNA target prediction programs, outnumbering all
other integrated resources of predicted miRNA targets,
including miRGator (58), miRGen (31) and miRNAMap
(59) (Table 2).
Table 1. Comparison in data content between TarBase and miRecords
Total number
of miRNAs
Total number of
target genes
Total number
of records
Number of
low-throughput
records
a
Number of
human miRNAs
Number of
human target genes
Number of
human records
TarBase (57) 128 570 626 279 62 415 458
miRecords 301 902 1135 639 125 651 778
aLow-throughput records refer to records from nonDNA-microarray studies.
Table 2. Comparison in miRNA target prediction programs implemented among integrated miRNA target resources
Tool URL DIANA-
microT
Micro-
Inspector
mi-
Randa
mi-
Target
Mir-
Target2
NBmir-
Tar
Pic-
Tar
PITA RNA 22 RNA
Hybrid
TargetScan/
TargetScanS
miRGator (58) http://genome.ewha.ac.kr/
miRGator/miRGator.html
ˇˇ ˇ
miRGen (31) http://www.diana.pcbi.
upenn.edu/miRGen.html
ˇˇ ˇ ˇ
MiRNAMap (59) http://mirnamap.mbc.
nctu.edu.tw/
ˇˇ ˇ
miRecords http://miRecords.umn.edu/
miRecords
ˇˇˇ ˇ ˇ ˇ ˇ ˇ ˇˇ ˇ
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